Science Explorer Back to mapMap
Discussion
Company · Jerusalem · Israel

Intec Pharma (Israel)

intecpharma.comROR OpenAlex
Research works
3
▼ 100% vs 2018-21
Citations
54
17.5 per fractional work
Top-10% rate
11.4%
all institutions 10.0%
International
24%
world 18%
Intec Pharma (Israel)

Not ranked overall: Intec Pharma (Israel) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Intec Pharma (Israel) work in?

In all years, 87% of research at Intec Pharma (Israel) is in Health Sciences, 6% in Life Sciences. Its largest fields are Medicine (74%), Health Professions (13%), Pharmacology, Toxicology and Pharmaceutics (6%). It does 1.5× the world's share of Health Sciences.

Health Sciences: 3 fractional works · 87.1% of its workMedicine: 2 fractional works · 74.2% of its workHealth Professions: 0 fractional works · 12.9% of its workLife Sciences: 0 fractional works · 6.5% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 6.5% of its workPhysical Sciences: 0 fractional works · 6.5% of its workChemistry: 0 fractional works · 6.5% of its workALL ITS WORKIntec Pharma(Israel)3fractional works, all years
Life Sciences6%Physical Sciences6%Health Sciences87%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 4 fields, with their numbers
    1. Medicine274.2%
    2. Health Professions012.9%
    1. Pharmacology, Toxicology and Pharmaceutics06.5%
    1. Chemistry06.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Intec Pharma (Israel)?

The most cited paper from Intec Pharma (Israel) is "Gastroretentive Accordion Pill: Enhancement of riboflavin bioavailability in humans" (Leonid Kagan, Noa Lapidot, Michel Afargan et al., 2006), with 80 citations. Next come "Pharmacokinetics and efficacy of a novel formulation of carbidopa-levodopa (Accordion Pill®) in Parkinson's disease" (46) and "The Accordion Pill ® : Unique Oral Delivery to Enhance Pharmacokinetics and Therapeutic Benefit of Challenging Drugs" (25).

Most cited papers
#PaperReleasedCitations
1 Gastroretentive Accordion Pill: Enhancement of riboflavin bioavailability in humans Leonid Kagan, Noa Lapidot, Michel Afargan et al. · Journal of Controlled Release 3 May 2006 80
2 Pharmacokinetics and efficacy of a novel formulation of carbidopa-levodopa (Accordion Pill®) in Parkinson's disease Peter A. LeWitt, Nir Giladi, Nadav Navon · Parkinsonism & Related Disorders 22 May 2019 46
3 The Accordion Pill ® : Unique Oral Delivery to Enhance Pharmacokinetics and Therapeutic Benefit of Challenging Drugs Nadav Navon · Therapeutic Delivery 17 Jun 2019 25
4 Optimizing Delivery of Carbidopa/Levodopa via the Accordion Pill™: Comparative PK and Safety From 2 Randomized Crossover Studies in Healthy Volunteers (P2.040) Nadav Navon, Zeev Weiss, R. Michael Gendreau et al. · Neurology 10 Apr 2018 3
5 Gastric Retention of the Accordion Pill™: Results From MRI Studies With Parkinson’s Disease Patients and Healthy Volunteers (P2.8-050) Nadav Navon, R. Michael Gendreau · Neurology 9 Apr 2019 1
All 5 most cited papers, with filters and sorting

Which research topics does Intec Pharma (Israel) publish most on?

By volume: Parkinson's Disease Mechanisms and Treatments, Gastroesophageal reflux and treatments, Dysphagia Assessment and Management and Neurological disorders and treatments.

Parkinson's Disease Mech…1Parkinson's Disease Mechanisms and Treatments: 1 fractional worksGastroesophageal reflux …0Gastroesophageal reflux and treatments: 0 fractional worksDysphagia Assessment and…0Dysphagia Assessment and Management: 0 fractional worksNeurological disorders and treatments: 0 fractional worksChild Nutrition and Feeding Issues: 0 fractional worksDrug Solubulity and Deli…0Drug Solubulity and Delivery Systems: 0 fractional worksAnalytical Methods in Pharmaceuticals: 0 fractional worksPharmaceutical studies and practices: 0 fractional worksGinkgo biloba and Cashew Applications: 0 fractional worksGastrointestinal motility and disorders: 0 fractional works
NeurologyGastroenterologySpeech and HearingPsychiatry and Mental health4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Parkinson's Disease Mechanisms and Treatments Neurology 1 works
  2. 2 Gastroesophageal reflux and treatments Gastroenterology 0 works
  3. 3 Dysphagia Assessment and Management Speech and Hearing 0 works
  4. 4 Neurological disorders and treatments Neurology 0 works
  5. 5 Child Nutrition and Feeding Issues Psychiatry and Mental health 0 works
  6. 6 Drug Solubulity and Delivery Systems Pharmaceutical Science 0 works
  7. 7 Analytical Methods in Pharmaceuticals Analytical Chemistry 0 works
  8. 8 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
  9. 9 Ginkgo biloba and Cashew Applications Complementary and alternative medicine 0 works
  10. 10 Gastrointestinal motility and disorders Gastroenterology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

with international co-authors24.3%domestic only75.7%

World: 18% is written across borders.

How has Intec Pharma (Israel)'s research output changed?

Output in 2022-2025 was 100% lower than in 2018-2021.

20102015

Other research institutions in Jerusalem

All research institutions in Jerusalem

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Intec Pharma (Israel). Posts are plain text and can be reported.